Navigation Links
Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer
Date:11/20/2008

BRIDGEWATER, N.J., Nov. 20 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC). If approved, trabectedin combined with DOXIL will provide a new, non-platinum treatment option for these patients in the United States.

The application follows the completion of a multicenter, randomized Phase III study, ET743-OVA-301, one of the largest studies conducted in ROC, comparing the combination of trabectedin and DOXIL to DOXIL alone in 672 patients. The study showed that patients treated with the combination treatment had a statistically significant improvement in the primary endpoint of progression-free survival (PFS, or the length of time during and after treatment in which the disease does not progress) compared to patients treated with DOXIL alone.

"This is a significant milestone in the development of trabectedin, an agent with a novel mechanism of action that holds promise for patients with relapsed ovarian cancer," said Craig Tendler, M.D., Vice President, Medical Affairs, Oncology/ Nephrology, Ortho Biotech Products, L.P. "We are confident in the strength of the data supporting the application and look forward to working with the FDA throughout the regulatory review process."

Relapsed ovarian cancer refers to epithelial carcinoma of the ovary that recurs after treatment. According to the National Cancer Institute (NCI), it is estimated that 21,650 women will be diagnosed with, and 15,520 women will die from ovarian cancer in the U.S. in 2008.

Trabectedin is being developed under a license from PharmaMar, and DOXIL is marketed by Ortho Biotech Products, L.P. in the U.S.

About t
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Orthopedic Oncology Fellowship Program at Mount Clemens Brings Highly Trained Surgeons to State
2. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
3. Dental Implants Effective for Orthodontic Treatment
4. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide
5. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
6. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
7. Orthodontists Offer Sweet Incentives for Tricky Halloween Treats
8. Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008
9. Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
10. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
11. Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Tara Haelle HealthDay ... Binge drinking among young adult men may lead to increased ... drinking didn,t cause a similar rise in blood pressure for ... In fact, when young adult women drank lightly or moderately, ... the study found. "This finding parallels studies in older ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
(Date:10/20/2014)... 20, 2014 With a mere 19 ... Crist made a brief fundraising stop at the ... , Fresh from a debate last night with his ... stage for the first seven minutes because Crist had ... described the incident in one word: "weird." , Before ...
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 hc1.com ... a secure cloud solution that enables healthcare organizations ... the ultimate healthcare-specific customer relationship management (“CRM”) solution. ... the unique needs of the healthcare industry, the ... for providers and patients by combining healthcare CRM, ...
Breaking Medicine News(10 mins):Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... who are pre-, perimenopausal with dense breasts benefit most, ... For some women, digital mammography is a better bet ... Women under the age 50 with dense breasts who ... digital mammograms, said study author Dr. Etta Pisano, the ...
... its most selective filter to keep it from clogging with ... St. Louis reveal in a new study. , Researchers ... more vulnerable to dysfunction and disease. , "We speculate ... the filter that can damage it," says senior author Andrey ...
... Xoft, Inc., developer of the,Axxent(R) Electronic ... in,radiation oncology and non-invasive neurosurgery solutions, announced ... agreement., Under the agreement, Elekta will ... Electronic Brachytherapy in the radiation oncology,market. This ...
... Denver Museum of Nature & Science Reveals Plans for New $8 Million ... Interactive Health Science Exhibition ... Jan. 29 Beginning in April 2009, residents and,visitors to the Denver ... their health in ways they have never experienced at a museum,-- or ...
... ... Compliance, and Lowers Costs, NEWARK and EAST BRUNSWICK, N.J., ... empirical,data demonstrating the effectiveness of the Patient Centered Medical Home,(PC-MH), ... their personal physicians and -- when appropriate -- the,patient,s family. ...
... the American Roentgen Ray Society to add more journals ... , BioMed Central, the open access publisher of peer-reviewed ... 4,200 images to the GoldMiner collection. The collection now ... GoldMiner speeds your search for radiology images by quickly ...
Cached Medicine News:Health News:Digital Mammography Better Than Film for Some Women 2Health News:Digital Mammography Better Than Film for Some Women 3Health News:Breakdown of kidney's ability to clean its own filters likely causes disease 2Health News:Breakdown of kidney's ability to clean its own filters likely causes disease 3Health News:Xoft Signs Sales Development Agreement With Elekta 2Health News:Xoft Signs Sales Development Agreement With Elekta 3Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 2Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 3Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 4Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 5Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 6Health News:Ground Breaking Program Improves Diabetes Patient Outcomes 2Health News:Ground Breaking Program Improves Diabetes Patient Outcomes 3
(Date:10/22/2014)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a ... reported financial results for the second fiscal quarter ended ... , Revenues of $53.9 million, up 18% over last ... up 33% over last year,s comparable quarter. ... Reference Laboratories (AVRL) of $3.5 million, up 50% over ...
(Date:10/22/2014)... , Oct. 22, 2014 InVivo Therapeutics Holdings ... is revolutionizing spinal cord injury (SCI) treatment ... shown to outperform in tissue regrowth in the spinal ... Made from an FDA approved polymer, the scaffold ultimately ... harmless to the human body. NVIV has recently attracted ...
(Date:10/22/2014)... and AUSTIN, Texas , ... PureMHC LLC today announced they have entered into ... antibody-based immunotherapies designed to target cancers. ... peptides displayed on the surfaces of tumor cells ... targets (PTTs), derived from proteins that play a ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2
... YORK, March 27 The Michael J. Fox ... million total to seven research teams working to ... awarded under the Foundation,s Improving Delivery of ... program is designed to address two major challenges ...
... March 26 Sleep disordered breathing, also ... National Football League (NFL) players, and particularly in linemen, ... players, adds to the growing body of research examining ... investigators say. The study will be presented Tuesday, March ...
Cached Medicine Technology:Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease 2Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea 2Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea 3
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... fiber reinforced polymer material emulates the biomechanical ...
... bone graft substitute (beta-tricalcium ... Chronos is an advantageous ... It shortens operative time, ... quantity and quality of ...
... bone regeneration scaffold. Its ... composite ensures ideal osteoconductivity, ... structure maximizes permeability even ... the most meaningful measure ...
Medicine Products: